← All trials
NCT03010241
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Nov 1, 2019
- Completion date
- May 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 188
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- Hebei UniversityCollaborator
- Anhui College of Traditional Chinese MedicineCollaborator
- Zhengzhou UniversityCollaborator
- Hubei University of Chinese MedicineCollaborator
- China Academy of Chinese Medical SciencesReponsible party - principal investigator
- Liaoning Hospital of Traditional Chinese MedicineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.